We are at the leading edge of recent advances in biology and informatics. Our innovative approach to drug discovery is truly novel, unique and also highly productive
e-therapeutics combines cutting-edge computer technologies with unique approach to network biology to discover new and better drugs more quickly and cheaply
We are a UK-based company listed (ETX.L) on the Alternative Investment Market (AIM), London Stock Exchange's international market for smaller, growing companies
Our latest News and Publications
What are you looking for?